September 2023 - Monthly Update
Kaitlyn Richardson - Sep 01, 2023
Listen Here:
Your portfolio performance was break even to slightly down in August. It remains with positive performance over the last 12 months.
Stock markets unwound some of their prior month’s gains. This type of consolidation is normal following the positive first half of the year.
Bond markets were steady and positive. There is a growing consensus that overnight interest rates have peaked. The expanding stability in bond markets is building our confidence that we have effectively entered the plateau stage of this interest rate cycle. The next phase is interest rate cuts and an easing of financial conditions for the economy.
On the economic front, the United States (U.S.) Is widening its lead over Canada. The U.S. posted another positive quarter (Q2) for gross domestic product (GDP) while Canada's GDP contracted by 0.2%.
When the time comes for interest rate cuts the motivation by our respective central banks will reflect this difference.
Rate cuts in Canada will be intended to help cushion a slowing economy. In the U.S., rate cuts will provide fuel for economic expansion while their inflationary headwinds continue to fade.
Quarterly earnings were better than expected and "artificial intelligence (AI)” replaced the word "recession" as a keyword to accompany results in the U.S.. There, businesses are using AI software applications to reduce the waste (of time and resource) which increases what is left over as profits. AI is not replacing people for jobs. Everyone that wants a job has a job in North America.
As is often the case, the domestic U.S. economy will lead the cycle of expansion with Canada to follow.
We continue to be realistic and constructive on the longevity and duration of the current cycle of growth.
You and your investments are in a strong position.
The view from Brian Belski, BMO's Chief Investment Strategist:
Stocks in your portfolio that made a new 52 week high this past month:
Mastercard*
Stocks in your portfolio that made a new 52 week low this past month:
Bristol-Myers*, Telus*
The Loonie declined by two cents versus the U.S. dollar to:
$0.74
Thank you,
Ian, Gab, Kaitlyn & Nataliia